As a highly heterogeneous disease, breast cancer has been classified into five subtypes based on the histological and molecular characteristics: triple-negative, human epidermal growth factor receptor 2 (HER2)-enriched, luminal B-like HER2 positive, luminal B-like HER2 negative, and luminal A-like [2-3]. This evidence concerns the gene ERBB2 and breast cancer.